For Immediate Release
Chicago, IL – January 12, 2016 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Direxion Daily S&P Biotech Bear 3x Shares (LABD), VelocityShares 3x Inverse Crude ETN (DWTI), ProShares UltraProShort Nasdaq Biotechnology (ZBIO), Direxion Daily FTSE China Bear 3x Shares (YANG) and Direxion Daily Semiconductor Bear 3x Shares ( SOXS).
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.
Here are highlights from Monday’s Analyst Blog:
Inverse Leverage ETFs Soaring to Start 2016
As fresh signs of a slowdown in China and a relentless slide in crude sparked off fears of a global slowdown, the U.S. stocks posted their worst five-day start to the year in history. The S&P 500 index plunged 6% while Dow Jones tumbled 6.2% last week. The tech-heavy Nasdaq Composite index, which outperformed last year, lost 7.3%.
Additionally, a strong dollar, geopolitical tensions in the Middle East and weak corporate earnings are weighing heavily on investor sentiment. This is especially true as earnings in the S&P 500 are projected to decline 5.3% for Q4 2015. This would mark three consecutive quarters of a year-over-year decline in earnings since Q1 2009 to Q3 2009, as per the earnings Factset.
Amid myriad woes, investors have little reason to believe that the bull market will complete its seventh year on March 9and thus shunned U.S. equities. According to etf.com, investors pulled out $5.8 billion in capital from U.S. equity ETFs.
This has resulted in huge demand for inverse or leveraged inverse ETFs for investors seeking to make big gains in a short span. In fact, many products provided outsized gains (over 30%) in the first week of 2016, though these involve a great deal of risk when compared to traditional products. Below, we have highlighted five such ETFs that crushed the market last week and should continue doing so at least for the near term if global sentiments remain volatile (read: Inverse Equity ETFs to Tackle the Slump).
These products either create an inverse long/short position or leveraged inverse long/short position in the underlying index through the use of swaps, options, future contracts and other financial instruments.
Direxion Daily S&P Biotech Bear 3x Shares (LABD)
This product seeks to deliver thrice (3x or 300%) the inverse (opposite) daily performance of the S&P Biotechnology Select Industry Index. The fund has amassed $33.4 million in its asset base and average daily volume of more than 632,000 shares. It charges investors 95 bps in annual fees and expenses. The ETF delivered whopping returns of 51.8% in the first week of 2016 (read: Intro Guide to Leveraged Biotech ETF Investing ).
VelocityShares 3x Inverse Crude ETN (DWTI)
This product provides three times inverse exposure to the daily performance of the S&P GSCI Crude Oil Index Excess Return. The ETN is a bit pricey as it charges 1.35% in annual fees while average daily volume is solid at 1.4 million shares. It has managed $374 million in its asset base and surged 38.4% last week.
ProShares UltraProShort Nasdaq Biotechnology (ZBIO)
This fund seeks to deliver thrice the inverse performance of the NASDAQ Biotechnology Index. It has accumulated $12 million in its AUM and charges 95 bps in annual fees. Average trading volume is moderate, exchanging about 73,000 shares a day in hand. The fund gained nearly 38.1% in the same time frame.
Direxion Daily FTSE China Bear 3x Shares (YANG)
This fund provides thrice the inverse return of the FTSE China 50 Index. The product has AUM of around $82.8 million and sees good trading volume of 251,000 shares a day on average. Expense ratio came in at 0.95%. YANG retuned nearly 36.2% over the past one-week period (read: China Crash Spoils New Year Mood: ETFs in Focus ).
Direxion Daily Semiconductor Bear 3x Shares (SOXS)
This ETF provides three times inverse exposure to the PHLX Semiconductor Sector Index. It charges 0.95% in annual fees and trades in average daily volume of more than 117,000 shares. It has managed $45.9 million in its asset base and gained 33.3% last week.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today. Find out What is happening in the stock market today on zacks.com.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
DIRX-D SP BBEAR (LABD): ETF Research Reports
VEL-3X INV CRD (DWTI): ETF Research Reports
PRO-ULT SH ND B (ZBIO): ETF Research Reports
DIR-D F CHIN BR (YANG): ETF Research Reports
DIR-D SM BR 3X (SOXS): ETF Research Reports
To read this article on Zacks.com click here.